All News about Mei Pharma Inc
![](https://www.businesswire.com/images/bwlogo_extreme.png)
MEI Pharma Reports First Quarter Fiscal Year 2023 Results and Operational Highlights
November 14, 2022
From MEI Pharma, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_19763.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/24/image31.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/21/image-snap.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_18733.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/07/wall-street-sign-green-signal-up-day.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From MEI Pharma, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
MEI Pharma Announces Changes to Board of Directors
September 22, 2022
From MEI Pharma, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_3141.jpeg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
MEI Pharma Reports Fiscal Year 2022 Results and Operational Highlights
September 08, 2022
From MEI Pharma, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8100.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_4879.jpeg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
MEI Pharma to Present at the H.C. Wainwright 24th Annual Global Investment Conference 2022
September 06, 2022
From MEI Pharma, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
September 01, 2022
From MEI Pharma, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From MEI Pharma, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/07/18/bz-pharma_0.jpg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_2019.jpeg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20220610005042/en/1482594/5/Kaplan-Meier.jpg)
![](https://mms.businesswire.com/media/20220604005001/en/1475236/5/Image.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2022/06/01/premkt_movers.png?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.